Clinical Trial Update: Sit Less, Interact and Move More (SLIMM) 2 Study [Phase 2]

View source ↗

Summary

A Phase 2 trial update indicates the SLIMM 2 study evaluating Sit Less, Interact and Move More in patients with chronic kidney disease and obesity is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Obesity

Snippet

Sponsor: Srinvasan Beddhu | Conditions: Chronic Kidney Diseases, Obesity | Phase 2 | Status: RECRUITING